Mitochondrial Pathology in Muscle of a Patient with a Novel Parkin Mutation

REFERENCES

• Abbruzzese G., Pigullo S., Schenone A., Bellone E., Marchese R., Di Maria E., et al. Does parkin play a role in the peripheral nervous system? A family report. Movement Disorders 2004; 19: 978–981
   PubMed Web of Science ®Google Scholar
• Casali C., Bonifati V., Santorelli F. M., Casari G., Fortini D., Patrignani A., et al. Mitochondrial myopathy, parkinsonism, and multiple mtDNA deletions in a Sephardic Jewish family. Neurology 2001; 56: 802–805
   PubMed Web of Science ®Google Scholar
• Darios F., Corti O., Lucking C. B., Hampe C., Muriel M. P., Abbas N., et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Human Molecular Genetics 2003; 12: 517–526
   PubMed Web of Science ®Google Scholar
• DiMauro S., Tanji K., Bonilla E., Pallotti F., Schon E. A. Mitochondrial abnormalities in muscle and other aging cells: Classification, causes, and effects. Muscle Nerve 2002; 26: 597–607
   PubMed Web of Science ®Google Scholar
• Dogu O., Johnson J., Hernandez D., Hanson M., Hardy J., Apaydin H., et al. A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion. Movement Disorders 2004; 19: 812–816
   PubMed Web of Science ®Google Scholar
• Fahn S., Elton R. L., members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease, Volume 2, S. Fahn, C. D. Marsden, M. Goldstein, D. B. Calne. Macmillan Healthcare Information, Florham Park, NJ 1987; 153–163
   Google Scholar
• Gibb W. R., Lees A. J. The relevance of the Lewy Body pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 1988; 51: 745–752
   PubMed Web of Science ®Google Scholar
• Greene J. C., Whitworth A. J., Kuo I., Andrews L. A., Feany M. B., Pallanck L. J. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proceedings of the National Academy of Sciences 2003; 100: 4078–4083
   PubMed Web of Science ®Google Scholar
• Hattori N., Mizuno Y. Pathogenetic mechanisms of parkin in Parkinson's disease. Lancet 2004; 364: 722–724
   PubMed Web of Science ®Google Scholar
• Hedrich K., Eskelson C., Wilmot B., Marder K., Harris J., Garrels J., et al. Distribution, type, and origin of Parkin mutations: Review and case studies. Movement Disorders 2004; 19: 1146–1157
   PubMed Web of Science ®Google Scholar
• Hoehn M. M., Yahr M. D. Parkinsonism: Onset, progression and mortality. Neurology 1967; 17: 427–442
   PubMed Web of Science ®Google Scholar
• Hyun D. H., Lee M. H., Hattori N., Kubo S. I., Mizuno Y., Halliwell B., et al. Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. The Journal of Biological Chemistry 2002; 277: 28572–28577
   PubMed Web of Science ®Google Scholar
• Kann M., Jacobs H., Mohrmann K., Schumacher K., Hedrich K., Garrels J., et al. Role of parkin mutations in 111 community-based patients with early-onset parkinsonism. Annals of Neurology 2002; 51: 621–625
   PubMed Web of Science ®Google Scholar
• Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605–608
   PubMed Web of Science ®Google Scholar
• Kuroda Y., Mitsui T., Kunishige M., Matsumoto T. Parkin affects mitochondrial function and apoptosis in neuronal and myogenic cells. Biochemical and Biophysical Research Communications 2006b; 348: 787–793
   PubMed Web of Science ®Google Scholar
• Kuroda Y., Mitsui T., Kunishige M., Shono M., Akaike M., Azuma H., et al. Parkin enhances mitochondrial biogenesis in proliferating cells. Human Molecular Genetics 2006a; 15: 883–895
   PubMed Web of Science ®Google Scholar
• Lohmann E., Periquet M., Bonifati V., Wood N. W., De Michele G., Bonnet A. M., et al. How much phenotypic variation can be attributed to parkin genotype?. Annals of Neurology 2003; 54: 176–85
   PubMed Web of Science ®Google Scholar
• Lucking C. B., Durr A., Bonifati V., Vaughan J., De Michele G., Gasser T., et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. The New England Journal of Medicine 2000; 342: 1560–1567
   PubMed Web of Science ®Google Scholar
• Matsumine H., Saito M., Shimoda-Matsubayashi S., Tanaka H., Ishikawa A., Nakagawa-Hattori Y., et al. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2–27. American Journal of Human Genetics 1997; 60: 588–596
   PubMed Web of Science ®Google Scholar
• Narendra D., Tanaka A., Suen D. F., Youle R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. The Journal of Cell Biology 2008; 183: 795–803
   PubMed Web of Science ®Google Scholar
• Paciello O., Wojcik S., Engel W. K., McFerrin J., Askanas V. Parkin and its association with alpha-synuclein and AbetaPP in inclusion-body myositis and AbetaPP-overexpressing cultured human muscle fibers. Acta Myologica 2006; 25: 13–22
   PubMedGoogle Scholar
• Palacino J. J., Sagi D., Goldberg M. S., Krauss S., Motz C., Wacker M., et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. The Journal of Biological Chemistry 2004; 279: 18614–18622
   PubMed Web of Science ®Google Scholar
• Park J., Lee S. B., Lee S., Kim Y., Song S., Kim S., et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006; 441: 1157–1161
   PubMed Web of Science ®Google Scholar
• Periquet M., Latouche M., Lohmann E., Rawal N., De Michele G., Ricard S., et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 2003; 126: 1271–1278
   PubMed Web of Science ®Google Scholar
• Pesah Y., Pham T., Burgess H., Middlebrooks B., Verstreken P., Zhou Y., et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 2004; 131: 2183–2194
   PubMed Web of Science ®Google Scholar
• Rosen K. M., Veereshwarayya V., Moussa C. E. H., Fu Q., Goldberg M. S., Schlossmacher M. G., et al. Parkin protects against mitochondrial toxins and β-amyloid accumulation in skeletal muscle cells. The Journal of Biological Chemistry 2006; 281: 12809–12816
   PubMed Web of Science ®Google Scholar
• Serdaroglu P., Tasli H., Hanagasi H. A., Emre M. Parkin expression in human skeletal muscle. Journal of Clinical Neuroscience 2005; 12: 927–929
   PubMed Web of Science ®Google Scholar
• Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nature Genetics 2000; 25: 302–305
   PubMed Web of Science ®Google Scholar
• Simon D. K., Pulst S. M., Sutton J. P., Browne S. E., Beal M. F., Johns D. R. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 1999; 53: 1787–1793
   PubMed Web of Science ®Google Scholar
• Winklhofer K. F., Henn I. H., Kay-Jackson P. C., Heller U., Tatzelt J. Inactivation of parkin by oxidative stress and C-terminal truncations: A protective role of molecular chaperones. The Journal of Biological Chemistry 2003; 278: 47199–47208
   PubMed Web of Science ®Google Scholar